Venture Capital

Updated:

InnovVentures Partners

InnovVentures Partners delivers competitive advantage for Biotech and Medtech start-ups. It was founded by professionals experienced with major Pharma...

InnovVentures Partners logo

InnovVentures Partners

InnovVentures Partners delivers competitive advantage for Biotech and Medtech start-ups. It was founded by professionals experienced with major Pharma companies, Biotech/MedTech start-ups and venture capital. The firm supports launching activities, establishing affiliates, negotiating contracts and raising funds, with a focus on business plan analysis and financial services including part-time and interim management.

General information

Firm type

Venture Capital

Location

Region

Europe

Country

Switzerland

City

Basel

Corporate office

Basel, Switzerland

Principals

Brice Suire

Director

Kevin Fox

Director

Sector focus

Biotech and Medtech

Frequently asked questions

What investment stages does InnovVentures Partners typically target?

The firm targets an unusually wide stage range. On the early side, it covers startup and early-stage venture investing. On the later side, it pursues buyout transactions. The spin-off strategy occupies a middle ground, often involving mature business units carved from larger corporates. This multi-stage mandate is operationally demanding and rare for a small firm.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Basel Venture Capital profiles